0001209191-19-060615.txt : 20191216 0001209191-19-060615.hdr.sgml : 20191216 20191216151019 ACCESSION NUMBER: 0001209191-19-060615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191212 FILED AS OF DATE: 20191216 DATE AS OF CHANGE: 20191216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taglietti Marco CENTRAL INDEX KEY: 0001408870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 191286834 MAIL ADDRESS: STREET 1: C/O FOREST LABORATORIES, INC. STREET 2: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562181648 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-12 0 0001178253 SCYNEXIS INC SCYX 0001408870 Taglietti Marco 1 EVERTRUST PLAZA, 13TH FLOOR JERSEY CITY NJ 07302-6548 1 1 0 0 Chief Executive Officer Common Stock 2019-12-12 4 P 0 166667 0.90 A 693682 D Common Stock Warrant (right to buy) 1.10 2019-12-12 4 P 0 166667 A 2019-12-12 Common Stock 166667 166667 D Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant. The warrant expires on the earlier of (i) such date that is six months after the issuer publicly announces the approval from the U.S. Food and Drug Administration for ibrexafungerp for the treatment of vulvovaginal candidiasis and (ii) June 12, 2023. /s/ Robert F. Joyce Jr., by Power of Attorney 2019-12-16